Host Genomic Profiling in Human Immunodeficiency Virus Infection

Kevin V. Shianna; Amalio Telenti

doi:10.1128/9781555816834.ch53

Chapter 53 : Host Genomic Profiling in Human Immunodeficiency Virus Infection

Authors: Kevin V. Shianna¹, Amalio Telenti²

VIEW AFFILIATIONS HIDE AFFILIATIONS

Affiliations: 1: Genomic Analysis Facility, Institute for Genome Sciences and Policy, Duke University, Durham, NC 27708; 2: Institute of Microbiology, University Hospital Center and University of Lausanne, 1011 Lausanne, Switzerland

Content Type: Reference

Publication Year: 2011

Category: Clinical Microbiology; Bacterial Pathogenesis

Book DOI: 10.1128/9781555816834

Chapter DOI: 10.1128/9781555816834.ch53

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:

Host Genomic Profiling in Human Immunodeficiency Virus Infection, Page 1 of 2

< Previous page | Next page > /docserver/preview/fulltext/10.1128/9781555816834/9781555814977_Chap53-1.gif /docserver/preview/fulltext/10.1128/9781555816834/9781555814977_Chap53-2.gif

Abstract:

Host data can be presented under the concept of genetics of candidate genes, genome-wide studies, and the more specific areas of comparative and evolutionary genetics, and pharmacogenetics. A parallel development is taking place in the field of pharmacogenetics that aims at the identification of genetic variants that modulate drug response, pharmacokinetics, and toxicity. This chapter emphasizes the technical and technological possibilities in genetics and genomics for the study of host susceptibility to human immunodeficiency virus type 1 infection. Study phenotypes should be easily measurable and reliable (i.e., low intraindividual variability), but variable (i.e., high interindividual variability). In the HIV field these include standardized quantitative traits, such as viral load, CD4 T-cell count, and other biomarkers of disease. Clinical endpoints are best studied if they are not the composite result of multiple biological and environmental factors. All essentially involve a set of probes on an array and require amplification and labeling of cDNA/cRNA followed by hybridization to the probes on the array. Recently, groups have started to perform sequencing experiments on the entire transcriptome. This approach is similar to sequencing an entire human genome, except the input is cDNA rather than genomic DNA. It is too early to measure the full potential of large-scale genome research in HIV-1 infection. However, some general principles can be drawn. The first aspect relates to the fact that the human genome is a canvas that provides reference to multiple types of data. The second aspect concerns the use of new knowledge.

Citation: Shianna K, Telenti A. 2011. Host Genomic Profiling in Human Immunodeficiency Virus Infection, p 833-840. In Persing D, Tenover F, Tang Y, Nolte F, Hayden R, van Belkum A (ed), Molecular Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555816834.ch53

Key Concept Ranking

Human immunodeficiency virus 1: 0.4957319
RNA Polymerase I: 0.4017857

0.4957319

Highlighted Text: Show | Hide

Full text loading...

Figures

Host Genomic Profiling in Human Immunodeficiency Virus Infection

[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555816834.ch53-1,webId=/content/author/10.1128/9781555816834.ch53-1,properties={foaf_givenname=Kevin V., foaf_name=Kevin V. Shianna, foaf_surname=Shianna, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555816834.ch53-aff1]]}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555816834.ch53-2,webId=/content/author/10.1128/9781555816834.ch53-2,properties={foaf_givenname=Amalio, foaf_name=Amalio Telenti, foaf_surname=Telenti, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555816834.ch53-aff2]]}]]

/content/10.1128/9781555816834.ch53.ch53fig01

FIGURE 1

Pattern of evolution of primate proteins involved in antiviral intrinsic cellular defense (TRIM5α and -22 and APOBE3G and -3F) and in innate immunity (DC-SIGN family and Toll-like receptors) in comparison with a random set of 19 proteins. Analysis estimated the Ka/Ks values (ratio of the rate of nonsynonymous substitutions [Ka] to the rate of synonymous substitutions [Ks]), which can be used as an indication of positive selection on a protein-coding gene. Analysis included human, chimpanzee, orangutan, rhesus monkey, and marmoset genome data. Bars indicate median values.

10.1128/9781555816834/f0835-01_thmb.gif

10.1128/9781555816834/f0835-01.gif

FIGURE 1

References

/content/book/10.1128/9781555816834.ch53

1. Antonarakis, S. E.,, and J. S. Beckmann. 2006. Mendelian disorders deserve more attention. Nat. Rev. Genet. 7: 277– 282.

2. Barbour, J. D.,, and R. M. Grant. 2005. The role of viral fitness in HIV pathogenesis. Curr. HIV/AIDS Rep. 2: 29– 34.

3. Berro, R.,, C. de la Fuente,, Z. Klase,, K. Kehn,, L. Parvin,, A. Pumfery,, E. Agbottah,, A. Vertes,, S. Nekhai, and, F. Kashanchi. 2007. Identifying the membrane proteome of HIV-1 latently infected cells. J. Biol. Chem. 282: 8207– 8218.

4. Bleiber, G.,, M. May,, R. Martinez,, P. Meylan,, J. Ott,, J. Beckmann, and, A. Telenti. 2005. Use of a combined ex vivo/in vivo population approach for screening of human genes involved in the human immunodeficiency virus type 1 life cycle for variants influencing disease progression. J. Virol. 79: 12674– 12680.

5. Brass, A. L.,, D. M. Dykxhoorn,, Y. Benita,, N. Yan,, A. Engelman,, R. J. Xavier,, J. Lieberman, and, S. J. Elledge. 2008. Identification of host proteins required for HIV infection through a functional genomic screen. Science 319: 921– 926.

6. Carrington, M.,, G. Nelson, and, S. J. O’Brien. 2001. Considering genetic profiles in functional studies of immune responsiveness to HIV-1. Immunol. Lett. 79: 131– 140.

7. Caulfield, T.,, A. L. McGuire,, M. Cho,, J. A. Buchanan,, M. M. Burgess,, U. Danilczyk,, C. M. Diaz,, K. Fryer-Edwards,, S. K. Green,, M. A. Hodosh,, E. T. Juengst,, J. Kaye,, L. Kedes,, B. M. Knoppers,, T. Lemmens,, E. M. Meslin,, J. Murphy,, R. L. Nussbaum,, M. Otlowski,, D. Pullman,, P. N. Ray,, J. Sugarman, and, M. Timmons. 2008. Research ethics recommendations for whole-genome research: consensus statement. PLoS Biol. 6: e73.

8. Chan, E. Y.,, W. J. Qian,, D. L. Diamond,, T. Liu,, M. A. Gritsenko,, M. E. Monroe,, D. G. Camp,, R. D. Smith, and, M. G. Katze. 2007. Quantitative analysis of human immunodeficiency virus type 1-infected CD4 + cell proteome: dysregulated cell cycle progression and nuclear transport coincide with robust virus production. J. Virol. 81: 7571– 7583.

9. Ciuffi, A.,, G. Bleiber,, M. Munoz,, R. Martinez,, C. Loeuillet,, M. Rehr,, M. Fischer,, H. Gunthard,, A. Oxenius,, P. Meylan,, S. Bonhoeffer,, D. Trono, and, A. Telenti. 2004. Entry and transcription as key determinants of differences in CD4 T-cell permissiveness to human immunodeficiency virus type 1 infection. J. Virol. 78: 10747– 10754.

10. Coiras, M.,, E. Camafeita,, T. Urena,, J. A. Lopez,, F. Caballero,, B. Fernandez,, M. R. Lopez-Huertas,, M. Perez-Olmeda, and, J. Alcami. 2006. Modifications in the human T cell proteome induced by intracellular HIV-1 Tat protein expression. Proteomics 6 (Suppl. 1) : S63– S73.

11. Draenert, R.,, T. M. Allen,, Y. Liu,, T. Wrin,, C. Chappey,, C. L. Verrill,, G. Sirera,, R. L. Eldridge,, M. P. Lahaie,, L. Ruiz,, B. Clotet,, C. J. Petropoulos,, B. D. Walker, and, J. Martinez-Picado. 2006. Constraints on HIV-1 evolution and immunodominance revealed in monozygotic adult twins infected with the same virus. J. Exp. Med. 203: 529– 539.

12. Dyer, M. D.,, T. M. Murali, and, B. W. Sobral. 2008. The landscape of human proteins interacting with viruses and other pathogens. PLoS Pathog. 4: e32.

13. Fellay, J.,, K. Boubaker,, B. Ledergerber,, E. Bernasconi,, H. Furrer,, M. Battegay,, B. Hirschel,, P. Vernazza,, P. Francioli,, G. Greub,, M. Flepp, and, A. Telenti. 2001. Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study. Lancet 358: 1322– 1327.

14. Fellay, J.,, K. V. Shianna,, D. Ge,, S. Colombo,, B. Ledergerber,, M. E. Weale,, K. Zhang,, C. Gumbs,, A. Castagna,, A. Cossarizza,, A. Cozzi-Lepri,, A. De Luca,, P. J. Easterbrook,, P. Francioli,, S. Mallal,, J. Martinez-Picado,, J. M. Miro,, N. Obel,, J. P. Smith,, J. Wyniger,, P. Descombes,, S. E. Antonarakis,, N. L. Letvin,, A. McMichael,, B. F. Haynes,, A. Telenti, and, D. B. Goldstein. 2007. A whole-genome association study of major determinants for host control of HIV-1. Science 317: 944– 947.

15. Frazer, K. A.,, D. G. Ballinger,, D. R. Cox, et al. 2007. A second generation human haplotype map of over 3.1 million SNPs. Nature 449: 851– 861.

16. Ge, D.,, K. Zhang,, A. C. Need,, O. Martin,, J. Fellay,, T. J. Urban,, A. Telenti, and, D. B. Goldstein. 2008. WGA-Viewer: software for genomic annotation of whole genome association studies. Genome Res. 18: 640– 643.

17. Giri, M. S.,, M. Nebozhyn,, L. Showe, and, L. J. Montaner. 2006. Microarray data on gene modulation by HIV-1 in immune cells: 2000–2006. J. Leukoc. Biol. 80: 1031– 1043.

18. Gorry, P. R.,, M. Churchill,, J. Learmont,, C. Cherry,, W. B. Dyer,, S. L. Wesselingh, and, J. S. Sullivan. 2007. Replication-dependent pathogenicity of attenuated nef-deleted HIV-1 in vivo. J. Acquir. Immune Defic. Syndr. 46: 390– 394.

19. Keiser, O.,, J. Fellay,, M. Opravil,, H. H. Hirsch,, B. Hirschel,, E. Bernasconi,, P. Vernazza,, M. Rickenbach,, A. Telenti,, H. Furrer, and the Swiss HIV Cohort Study. 2007. Adverse events to antiretrovirals in the Swiss HIV Cohort Study: impact on mortality and treatment modification. Antivir. Ther. 12: 1157– 1164.

20. Kerns, J. A.,, M. Emerman, and, H. S. Malik. 2008. Positive selection and increased antiviral activity associated with the PARP-containing isoform of human zinc-finger antiviral protein. PLoS Genet. 4: e21.

21. Loeuillet, C.,, S. Deutsch,, A. Ciuffi,, D. Robyr,, P. Taffe,, M. Munoz,, J. S. Beckmann,, S. E. Antonarakis, and, A. Telenti. 2008. In vitro whole-genome analysis identifies a susceptibility locus for HIV-1. PLoS Biol. 6: e32.

22. McCarthy, M. I.,, G. R. Abecasis,, L. R. Cardon,, D. B. Goldstein,, J. Little,, J. P. Ioannidis, and, J. N. Hirschhorn. 2008. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat. Rev. Genet. 9: 356– 369.

23. Molina, L.,, M. Grimaldi,, V. Robert-Hebmann,, L. Espert,, M. Varbanov,, C. Devaux,, C. Granier, and, M. Biard-Piechaczyk. 2007. Proteomic analysis of the cellular responses induced in uninfected immune cells by cell-expressed X4 HIV-1 envelope. Proteomics 7: 3116– 3130.

24. Mortazavi, A.,, B. A. Williams,, K. McCue,, L. Schaeffer, and, B. Wold. 2008. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat. Methods 5: 621– 628.

25. Munch, J.,, E. Rucker,, L. Standker,, K. Adermann,, C. Goffinet,, M. Schindler,, S. Wildum,, R. Chinnadurai,, D. Rajan,, A. Specht,, G. Gimenez-Gallego,, P. C. Sanchez,, D. M. Fowler,, A. Koulov,, J. W. Kelly,, W. Mothes,, J. C. Grivel,, L. Margolis,, O. T. Keppler,, W. G. Forssmann, and, F. Kirchhoff. 2007. Semen-derived amyloid fibrils drastically enhance HIV infection. Cell 131: 1059– 1071.

26. Munch, J.,, L. Standker,, K. Adermann,, A. Schulz,, M. Schindler,, R. Chinnadurai,, S. Pohlmann,, C. Chaipan,, T. Biet,, T. Peters,, B. Meyer,, D. Wilhelm,, H. Lu,, W. Jing,, S. Jiang,, W. G. Forssmann, and, F. Kirchhoff. 2007. Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide. Cell 129: 263– 275.

27. Naif, H. M.,, S. Li,, M. Alali,, J. Chang,, C. Mayne,, J. Sullivan, and, A. L. Cunningham. 1999. Definition of the stage of host cell genetic restriction of replication of human immunodeficiency virus type 1 in monocytes and monocyte-derived macrophages by using twins. J. Virol. 73: 4866– 4881.

28. Nelson, G. W.,, and S. J. O’Brien. 2006. Using mutual information to measure the impact of multiple genetic factors on AIDS. J. Acquir. Immune Defic. Syndr. 42: 347– 354.

29. O’Brien, S. J.,, and G. W. Nelson. 2004. Human genes that limit AIDS. Nat. Genet. 36: 565– 574.

30. Ortiz, M.,, G. Bleiber,, R. Martinez,, H. Kaessmann, and, A. Telenti. 2006. Patterns of evolution of host proteins involved in retroviral pathogenesis. Retrovirology 3: 11.

31. Ortiz, M.,, H. Kaessmann,, K. Zhang,, A. Bashirova,, M. Carrington,, L. Quintana-Murci, and, A. Telenti. 2008. The evolutionary history of the CD209 (DC-SIGN) family in humans and non-human primates. Genes Immun. 9: 483– 492.

32. Pereyra, F.,, M. M. Addo,, D. E. Kaufmann,, Y. Liu,, T. Miura,, A. Rathod,, B. Baker,, A. Trocha,, R. Rosenberg,, E. Mackey,, P. Ueda,, Z. Lu,, D. Cohen,, T. Wrin,, C. J. Petropoulos,, E. S. Rosenberg, and, B. D. Walker. 2008. Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. J. Infect. Dis. 197: 563– 571.

33. Picard, C.,, J. L. Casanova, and, L. Abel. 2006. Mendelian traits that confer predisposition or resistance to specific infections in humans. Curr. Opin. Immunol. 18: 383– 390.

34. Plummer, F. A.,, T. B. Ball,, J. Kimani, and, K. R. Fowke. 1999. Resistance to HIV-1 infection among highly exposed sex workers in Nairobi: what mediates protection and why does it develop? Immunol. Lett. 66: 27– 34.

35. Price, A. L.,, N. J. Patterson,, R. M. Plenge,, M. E. Wein-blatt,, N. A. Shadick, and, D. Reich. 2006. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38: 904– 909.

36. Purcell, S.,, B. Neale,, K. Todd-Brown,, L. Thomas,, M. A. Ferreira,, D. Bender,, J. Maller,, P. Sklar,, P. I. de Bakker,, M. J. Daly, and, P. C. Sham. 2007. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81: 559– 575.

37. Sabeti, P. C.,, P. Varilly,, B. Fry,, J. Lohmueller,, E. Hostetter,, C. Cotsapas,, X. Xie,, E. H. Byrne,, S. A. McCarroll,, R. Gaudet,, S. F. Schaffner,, E. S. Lander, and the International HapMap Consortium. 2007. Genomewide detection and characterization of positive selection in human populations. Nature 449: 913– 918.

38. Sawyer, S. L.,, M. Emerman, and, H. S. Malik. 2004. Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G. PLoS Biol. 2: E275.

39. Sawyer, S. L.,, M. Emerman, and, H. S. Malik. 2007. Discordant evolution of the adjacent antiretroviral genes TRIM22 and TRIM5 in mammals. PLoS Pathog. 3: e197.

40. Sawyer, S. L.,, L. I. Wu,, M. Emerman, and, H. S. Malik. 2005. Positive selection of primate TRIM5α identifies a critical species-specific retroviral restriction domain. Proc. Natl. Acad. Sci. USA 102: 2832– 2837.

41. Sirois, M.,, L. Robitaille,, R. Sasik,, J. Estaquier,, J. Fortin, and, J. Corbeil. 2008. R5 and X4 HIV viruses differentially modulate host gene expression in resting CD4+ T cells. AIDS Res. Hum. Retrovir. 24: 485– 493.

42. Telenti, A.,, and G. Bleiber. 2006. Host genetics of HIV1 susceptibility. Future Virol. 1: 55– 70.

43. Telenti, A.,, and D. B. Goldstein. 2006. Genomics meets HIV. Nat. Rev. Microbiol. 4: 9– 18.

44. Telenti, A.,, and U. M. Zanger. 2008. Pharmacogenetics of anti-HIV drugs. Annu. Rev. Pharmacol. Toxicol. 48: 227– 256.

Tables

Host Genomic Profiling in Human Immunodeficiency Virus Infection

/content/10.1128/9781555816834.ch53.ch53tab01

TABLE 1

Genetic variants modulating HIV-1 susceptibility and disease a

TABLE 1

Genetic variants modulating HIV-1 susceptibility and disease a

/content/10.1128/9781555816834.ch53.ch53tab02

TABLE 2

Comparative assessment of common genotyping and expression technologies

TABLE 2

Comparative assessment of common genotyping and expression technologies

/content/10.1128/9781555816834.ch53.ch53tab03

TABLE 3

Genome-wide and other high-throughput studies for the investigation of HIV-1 pathogenesis a

TABLE 3

Genome-wide and other high-throughput studies for the investigation of HIV-1 pathogenesis a